Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival

Oncogene
C SunS Srivastava

Abstract

Alteration of the AR functions due to amplification, overexpression and somatic mutation of the AR itself or altered interaction of AR with other cell growth regulatory proteins, may contribute to a significant subset of advanced prostate cancer (CaP). Very little is known about the pathways impacted by AR dysfunctions, although CaP associated AR alterations suggest the biological role of the AR dysfunction in disease progression. Comparative evaluations of wild type (wt) AR and mutant (mt) ARs in appropriate experimental models should provide a better understanding of the functional impact of AR alterations in CaP. Here, we provide direct evidence showing cell growth/cell survival promoting effects of the widely studied CaP associated AR mutation (T877A). In contrast to Ad-wtAR or Ad-control infected LNCaP or LAPC4 cells, Ad-mtAR (T877A) infected LNCaP or LAPC4 cells continued to grow in the androgen-deprived medium and exhibited an androgen independent AR-transcription factor activity. Further, Ad-mtAR (T877A) infected LNCaP or LAPC4 cells exhibited enhanced cell growth in the presence of lower concentrations of the synthetic androgen, R1881. Of note, Ad-mtAR (T877A) infected LNCaP cells showed striking resistance to cell gro...Continue Reading

References

Dec 20, 1990·The Journal of Steroid Biochemistry and Molecular Biology·A L SchuurmansE Mulder
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
Jun 10, 1998·Current Opinion in Oncology·E J Small
Apr 14, 1999·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Jan 19, 2000·Cell Death and Differentiation·C H Arrowsmith
Sep 30, 2000·Urological Research·Z CuligH Klocker
Nov 22, 2001·Journal of the National Cancer Institute·M E GrossmannD J Tindall
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward P Gelmann
Oct 1, 2003·The Prostate·Adrie van BokhovenM Scott Lucia
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Feb 3, 2004·Journal of Cellular Biochemistry·Mary-Ellen Taplin, Steven P Balk
Sep 16, 2004·The Prostate·Margarita L IoffeRobert S DiPaola
Nov 16, 2004·The Journal of Urology·Ke-Hung TsuiHorng-Heng Juang
Jan 12, 2005·The Journal of Urology·R E Sobel, M D Sadar
Jan 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Guangzhou HanNorman M Greenberg
Oct 6, 2005·Cancer Investigation·Javid JavidanRalph W de Vere White

❮ Previous
Next ❯

Citations

Mar 28, 2012·Pharmaceutical Research·Michael DanquahRam I Mahato
Sep 18, 2007·Medical Oncology·Victor ValdespinoPavel Pisa
Feb 14, 2007·Prostate Cancer and Prostatic Diseases·E RichterA Dobi
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sayuri TakahashiShigeaki Kato
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Akash KumarJay Shendure
Aug 16, 2008·The Journal of Biological Chemistry·Hongyun LiShiv Srivastava
Aug 19, 2008·The Journal of Biological Chemistry·Harryl D MartinezMichael E Wright
Jun 15, 2007·Pharmacogenomics·Franca D'AmicoGiuseppe Novelli
May 3, 2014·Acta Pharmacologica Sinica·Zhi-yun ZhangMing-wei Wang
Jan 5, 2014·Cancer Metastasis Reviews·Zoran Culig, Frédéric R Santer
Nov 20, 2012·Annual Review of Physiology·Takahiro MatsumotoShigeaki Kato
Feb 28, 2013·Molecular Cancer Therapeutics·Yu Chi YangMarianne D Sadar
Apr 29, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Jamey A Sarvis, Ian M Thompson
Dec 18, 2007·Neoplasia : an International Journal for Oncology Research·Fatouma AlimirahDivaker Choubey
Jan 14, 2009·Bioorganic & Medicinal Chemistry Letters·Jinming ZhouJian Hui Wu
Feb 27, 2007·The International Journal of Biochemistry & Cell Biology·Maria NietoWilliam C Hahn
Sep 30, 2009·IUBMB Life·Nigel BennettGlenda C Gobe
Feb 20, 2010·The American Journal of Pathology·Martin LigrPeng Lee
Sep 2, 2006·Critical Reviews in Oncology/hematology·H G van der Poel
Jun 16, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Yusuke Imamura, Marianne D Sadar
Sep 21, 2016·Endocrine-related Cancer·Damien A LeachCharlotte L Bevan
Jul 20, 2007·Molecular Endocrinology·Scott M Dehm, Donald J Tindall
Dec 20, 2018·Hormones & Cancer·Shafinaz ChowdhuryMark Trifiro
Oct 4, 2014·Oncotarget·Emma ShtivelmanChristopher P Evans
Aug 6, 2019·Frontiers in Endocrinology·Phoebe L SarkarColleen C Nelson
Jul 22, 2018·Endocrine·Ana Caroline HillebrandIlma Simoni Brum
Feb 27, 2017·Cancer Research·Jeffrey D ThomasFelix J Kim
Nov 30, 2006·Current Opinion in Oncology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis